Published October 30, 2013 by PR Web St. Louis, Missouri (PRWEB) October 30, 2013 The defective medical device attorneys at Carey Danis & Lowe are currently investigating Bard LifeStent cases following an…
Read More
Lawyers at Carey Danis & Lowe have been closely following recent news regarding Mirena lawsuits. Following growing adverse event reports filed with the U.S. Food and Drug Administration (FDA) as…
Read More
The U.S. Food & Drug Administration (FDA) issued an updated safety communication regarding metal-on-metal hip implants on January 17, 2013. The safety communication reports how metal-on-metal hip replacement systems by…
Read More
The latest development in the Ethicon multidistrict litigation (MDL) in the U.S. District Court for the Southern District of West Virginia, U.S. District Judge Joseph R. Goodwin filed pretrial order…
Read More
Five Multi-District Litigation trials regarding transvaginal mesh injuries are based out of the U.S. District Court, Southern District of West Virginia. These five MDLs relating to transvaginal mesh, vaginal slings,…
Read More
Published August 23, 2012 on LawsuitInformation.org It has been reported that Bayer, the German pharmaceutical giant responsible for the development of Yaz and Yasmin, the health threatening birth control pills…
Read More
In the Yaz, Yasmin, and Ocella multicounty litigation (MCL) in the Superior Court of New Jersey in Bergen County, the court filed a new case management order in mid-October. The…
Read More
In early November, the U.S. Food and Drug Administration (FDA) released a statement about its recent research into the incidence of excessive bleeding and Pradaxa use in patients with atrial…
Read More
On December 19, the U.S. Food and Drug Administration (FDA) released a safety announcement regarding the anticoagulant medicine known as Pradaxa. Pradaxa, known generically as dabigatran etexilate mesylate, is manufactured…
Read More
Though the drug manufacturer denies Pradaxa as a defective drug, the surmounting Pradaxa bleeding deaths, injuries, and lawsuits prove otherwise. Pradaxa was introduced onto the U.S. drug market in October…
Read More